Cargando…
Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
Alzheimer’s disease (AD) can be predicted either by serum or plasma biomarkers, and a combination may increase predictive power, but due to the high complexity of machine learning, it may also incur overfitting problems. In this paper, we investigated whether combining serum and plasma biomarkers wi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601501/ https://www.ncbi.nlm.nih.gov/pubmed/36292623 http://dx.doi.org/10.3390/genes13101738 |